NovaBridge Biosciences
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 |
|---|---|---|
Revenue | $0 | $237,995 |
Gross Profit | 237,995 | |
EBITDA | -72,684 | -7,438 |
EBIT | -72,900 | -8,989 |
Net Income | -30,787 | -6,828 |
Net Change In Cash | 0 | 237,995 |
Free Cash Flow | -14,596 | 13,147 |
Cash | 210,632 | 11,560,430 |
Basic Shares | 265,377 | 43,892 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $4,485 | $-10,697 |
Gross Profit | -858 | 4,485 | -10,697 | |
EBITDA | -12,620 | -368,250 | -339,936 | -356,596 |
EBIT | -13,476 | -375,358 | -347,621 | -366,078 |
Net Income | -6,614 | -162,257 | -1,465,694 | -967,520 |
Net Change In Cash | 0 | 0 | 4,485 | -10,697 |
Free Cash Flow | -20,604 | -384,770 | -73,018 | -1,148,635 |
Cash | 30,111 | 498,237 | 291,506 | 3,214,005 |
Basic Shares | 41,636 | 81,186 | 83,227 | 82,516 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.07 |
2026-03-31 | -$0.04 |
2025-12-31 | -$0.31 |
2025-09-30 | -$0.06 |